Cannabis Treating OSA - AASM Says No

The relationship between obstructive sleep apnea syndrome (OSA) and cardiovascular disease has been gradually recognized by the general public. OSA is often an occult disease, and the clinical detection rate is seriously insufficient. Many people with OSA were diagnosed when they show symptoms of cardiovascular disease.

The American Academy of Sleep Medicine(AASM) made a statement earlier this month and suggested that medical cannabis and synthetic cannabis extract should not be used to treat obstructive sleep apnea (OSA). On the basis of existing evidence, AASM has concluded that medical cannabis and/or its synthetic extracts should not be used for the treatment of OSA because of its unstable delivery method and lack of its effectiveness, tolerability and safety Sexual evidence is sufficient. Their position is that OSA should be excluded from the chronic disease list of the national medical marijuana project.

As mentioned in the AASM statement, limited evidence from small trials proves that dronabinol, a synthetic tetrahydrocannabinol, improves respiratory stability and benefits from treatment of OSA. However, side effects of treatment, such as drowsiness, have been reported in most patients. In addition, the long-term effects on sleep quality, tolerability and safety are still unknown.

The US Food and Drug Administration (FDA) has not approved the use of Dronabinol for the treatment of OSA, whereas in OSA patients, no drug cannabis and synthetic extracts have been studied except Dronabinol.

AASM believes that the use of medical marijuana to treat chronic and dangerous diseases such as OSA is worth worrying because

a) dronabinol is different from medical marijuana;
b) dronabinol has not been clinically studied for a long time, which may be the treatment of OSA.

Therefore, the concern is in the negative clinical results that may occur in OSA patients who have not been adequately treated, such as high blood pressure, heart disease or motor vehicle accidents.

“Unless there is sufficient scientific evidence to prove its safety and effectiveness, neither cannabis nor synthetic medical cannabis should be used to treat sleep apnea,” Ilena Rosen, chairman of the American Medical Association, told a press conference.



* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.